Urinary incontinence in prostate cancer patients treated with external beam radiotherapy

被引:46
作者
Liu, M
Pickles, T
Berthelet, E
Agranovich, A
Kwan, W
Tyldesley, S
McKenzie, M
Keyes, M
Morris, J
Pai, H
机构
[1] British Columbia Canc Agcy, Fraser Valley Ctr, Surrey, BC V3V 1Z2, Canada
[2] British Columbia Canc Agcy, Vancouver Ctr, Vancouver, BC V5Z 4E6, Canada
[3] British Columbia Canc Agcy, Vancouver Isl Ctr, Vancouver, BC V5Z 4E6, Canada
关键词
prostate neoplasms; radiotherapy; toxicity; urinary incontinence;
D O I
10.1016/j.radonc.2004.09.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: To describe the incidence of urinary incontinence among prostate cancer patients treated with external beam radiotherapy (RT) and to investigate associated risk factors. Patients and methods: One thousand and hundred ninety-two patients with >= 24 months follow-up were the subjects of this series. All patients received between 50 and 72 Gy in 20-37 fractions (median 66 Gy/33#). Post-RT urinary incontinence was scored by direct patient interviewing according to the modified RTOG/SOMA scale: Grade 1-occasional use of incontinence pads, Grade 2-intermittent use of incontinence pads, Grade 3-persistent use of incontinence pads, and Grade 4-permanent catheter. Risk-factors investigated were: age, diabetes, TURP prior to RT, elapsed time from TURP to RT, clinical stage, RT dose and presence of Grade >= 2 acute GU and GI toxicity. Non-parametric, actuarial univariate (Kaplan-Meier) and multivariate tests (MVA, Cox regression) were performed. Results: Median follow-up for the group is 52 months (24-109). Thirty-four patients (2.9%) had incontinence prior to RT, which was more common in TURP patients (7.8% vs 1.6% P < 0.001). These are excluded from further analysis. Fifty-seven patients (4.9%) developed Grade 1 incontinence, 7 (0.6%) Grade 2, and 7 (0.6%) Grade 3. There was no Grade 4 incontinence. Actuarial rates for Grade >= 1 and >= 2 incontinence at 5 years are 7 and 1.7%, respectively. Risk factors on MVA associated with the development of Grade 1 or worse incontinence are pre-RT TURP (5-year rates 10% vs 6%, P = 0.026), presence of Grade >= 2 acute GU toxicity (5-year rates 11% vs 5%, P = 0.002). Age, diabetes, clinical stage, elapsed time from TURP to RT, RT dose or fraction size, acute GI toxicity were not significant. Patients who underwent post-RT TURP or dilatation for obstructive symptoms (4.3%), were more likely to develop Grade 2-3 incontinence (5-year rate 8 vs 1.5%, P = 0.0015). Conclusions: Grade 2 or greater urinary incontinence is rare among patients who have been treated with external beam radiotherapy. Associated risk factors are pre-RT TURP and the presence of increased acute GU toxicity. Post-radiation TURP increases the risk of incontinence five-fold. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:197 / 201
页数:5
相关论文
共 20 条
[1]   Outcomes of external-beam radiation therapy for prostate cancer: A study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas [J].
Fowler, FJ ;
Barry, MJ ;
LuYao, G ;
Wasson, JH ;
Bin, L .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (08) :2258-2265
[2]   CARCINOMA OF THE PROSTATE - LOCAL-CONTROL WITH EXTERNAL BEAM RADIATION-THERAPY [J].
GIBBONS, RP ;
MASON, JT ;
CORREA, RJ ;
CUMMINGS, KB ;
TAYLOR, WJ ;
HAFERMANN, MD ;
RICHARDSON, RG .
JOURNAL OF UROLOGY, 1979, 121 (03) :310-312
[3]   PROSTATE-CANCER - POSTIRRADIATION INCONTINENCE [J].
GREEN, N ;
TREIBLE, D ;
WALLACK, H .
JOURNAL OF UROLOGY, 1990, 144 (02) :307-309
[4]   THE FREQUENCY AND MORBIDITY OF LOCAL TUMOR RECURRENCE AFTER DEFINITIVE RADIOTHERAPY FOR STAGE-C PROSTATE-CANCER [J].
HOLZMAN, M ;
CARLTON, CE ;
SCARDINO, PT .
JOURNAL OF UROLOGY, 1991, 146 (06) :1578-1582
[5]   SEQUELAE OF DEFINITIVE RADIATION-THERAPY FOR PROSTATE-CANCER LOCALIZED TO THE PELVIS [J].
JONLER, M ;
MESSING, EM ;
RITTER, MA ;
RHODES, PR ;
BRINKMANN, R ;
BRUSKEWITZ, RC .
UROLOGY, 1994, 44 (06) :876-882
[6]  
Jonler M, 1998, UROLOGY, V52, P1055, DOI 10.1016/S0090-4295(98)00449-X
[7]   Urinary incontinence following external-beam radiotherapy for clinically localized prostate cancer [J].
Lee, WR ;
Schultheiss, TE ;
Hanlon, AL ;
Hanks, GE .
UROLOGY, 1996, 48 (01) :95-98
[8]   Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation study [J].
Little, DJ ;
Kuban, DA ;
Levy, LB ;
Zagars, GK ;
Pollack, A .
UROLOGY, 2003, 62 (04) :707-713
[9]   Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy [J].
Liu, M ;
Pickles, T ;
Agranovich, A ;
Berthelet, E ;
Duncan, G ;
Keyes, M ;
Kwan, W ;
McKenzie, M ;
Morris, J ;
Pai, H ;
Tyldesley, S ;
Wu, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (01) :59-67
[10]   Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer [J].
Madalinska, JB ;
Essink-Bot, ML ;
de Koning, HJ ;
Kirkels, WJ ;
van der Maas, PJ ;
Schröder, FH .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (06) :1619-1628